R.J. Lewis responds to PM360’s questions.
Here are some of the questions:
- How can pharma shift its strategy to make sure they are still engaging with no-see physicians? Alternatively, how can reps maximize the time they get with the doctors they are able to see?
- How can pharma deliver more personalized experiences to HCPs? What new targeting and segmentation techniques can be used to help accomplish this?
- How does the changing role of the doctor in healthcare affect how pharma should engage with HCPs? What tools or services can pharma offer to HCPs to help make their jobs a little easier?
- What new technologies/techniques offer the most promise to help marketers better engage with HCPs?